Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
出版年份 2018 全文链接
标题
Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
作者
关键词
-
出版物
Frontiers in Immunology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-08-09
DOI
10.3389/fimmu.2018.01859
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma
- (2016) Hao Liu et al. Scientific Reports
- Big opportunities for small molecules in immuno-oncology
- (2015) Jerry L. Adams et al. NATURE REVIEWS DRUG DISCOVERY
- MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
- (2015) Hanbyoul Cho et al. BMC CANCER
- Human Anaplastic Thyroid Carcinoma Cells Are Sensitive to NK Cell-Mediated Lysis via ULBP2/5/6 and Chemoattract NK Cells
- (2014) E. Wennerberg et al. CLINICAL CANCER RESEARCH
- CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets
- (2014) M. T. M. Vossen et al. JOURNAL OF IMMUNOLOGY
- In Vitro Differentiation of Dendritic Cells in the Presence of Prostaglandin E2 Alters the IL-12/IL-23 Balance and Promotes Differentiation of Th17 Cells
- (2014) T. Khayrullina et al. JOURNAL OF IMMUNOLOGY
- Interleukin-17 Indirectly Promotes M2 Macrophage Differentiation through Stimulation of COX-2/PGE2 Pathway in the Cancer Cells
- (2014) Qingli Li et al. Cancer Research and Treatment
- A Soluble Fragment of the Tumor Antigen BCL2-associated Athanogene 6 (BAG-6) Is Essential and Sufficient for Inhibition of NKp30 Receptor-dependent Cytotoxicity of Natural Killer Cells
- (2013) Janina Binici et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ADAPted secretion of cytokines in NK cells
- (2013) Eric Vivier et al. NATURE IMMUNOLOGY
- Regulation of murine natural killer cell commitment
- (2013) Nicholas D. Huntington et al. Frontiers in Immunology
- Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
- (2012) G. Pietra et al. CANCER RESEARCH
- COX-2 Expression and Tumor Angiogenesis in Thyroid Carcinoma Patients among Northeast Chinese Population-Result of a Single-Center Study
- (2012) Bai Ji et al. International Journal of Medical Sciences
- Modulation of Host Natural Killer Cell Functions in Breast Cancer via Prostaglandin E2 Receptors EP2 and EP4
- (2012) Dawn M. Holt et al. JOURNAL OF IMMUNOTHERAPY
- Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan
- (2012) H.-H. Cheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcription factors involved in the regulation of natural killer cell development and function: an update
- (2012) Martha Luevano et al. Frontiers in Immunology
- A novel mechanism for cancer cells to evade immune attack by NK cells
- (2012) Benyamin Rosental et al. OncoImmunology
- Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4
- (2011) Dawn Holt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells
- (2011) Binqing Fu et al. IMMUNOLOGY
- The regulation of CD4+ T cell immune responses toward Th2 cell development by prostaglandin E2
- (2011) Yu-Shi Bao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Regulation of Immune Responses by Prostaglandin E2
- (2011) P. Kalinski JOURNAL OF IMMUNOLOGY
- Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
- (2011) Srinivas S. Somanchi et al. Jove-Journal of Visualized Experiments
- Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
- (2009) M. Balsamo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started